Singapore markets closed

AdaptHealth Corp. (AHCO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
17.89+0.13 (+0.73%)
At close: 04:00PM EDT
17.89 0.00 (0.00%)
After hours: 04:11PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.28B
Enterprise value 4.52B
Trailing P/E 20.47
Forward P/E 14.77
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.88
Price/book (mrq)1.08
Enterprise value/revenue 1.69
Enterprise value/EBITDA 7.17

Trading information

Stock price history

Beta (5Y monthly) 0.62
52-week change 3-30.39%
S&P500 52-week change 3-1.04%
52-week high 330.33
52-week low 311.40
50-day moving average 315.61
200-day moving average 320.21

Share statistics

Avg vol (3-month) 31.16M
Avg vol (10-day) 31.06M
Shares outstanding 5134.29M
Implied shares outstanding 6N/A
Float 853.37M
% held by insiders 124.90%
% held by institutions 178.07%
Shares short (12 May 2022) 49.22M
Short ratio (12 May 2022) 47.14
Short % of float (12 May 2022) 49.40%
Short % of shares outstanding (12 May 2022) 46.87%
Shares short (prior month 13 Apr 2022) 46.38M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 7.51%
Operating margin (ttm)10.61%

Management effectiveness

Return on assets (ttm)3.67%
Return on equity (ttm)10.43%

Income statement

Revenue (ttm)2.69B
Revenue per share (ttm)20.37
Quarterly revenue growth (yoy)46.50%
Gross profit (ttm)527.97M
EBITDA 573.25M
Net income avi to common (ttm)183.98M
Diluted EPS (ttm)0.79
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)119.43M
Total cash per share (mrq)0.89
Total debt (mrq)2.36B
Total debt/equity (mrq)111.11
Current ratio (mrq)1.39
Book value per share (mrq)15.76

Cash flow statement

Operating cash flow (ttm)323.75M
Levered free cash flow (ttm)-23.18M